Pompe Pregnancy Sub-Registry
Launched by GENZYME, A SANOFI COMPANY · Dec 1, 2007
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
**Summary of the Pompe Pregnancy Sub-Registry**
The Pompe Pregnancy Sub-Registry is a study aimed at understanding how pregnancy affects women with Pompe disease, which is a rare genetic condition that can lead to muscle weakness. This program tracks the experiences and outcomes of pregnant women who are already part of the Pompe Registry, whether or not they are receiving specific treatments for their condition. The goal is to gather important information about any complications during pregnancy and how the babies grow after birth. No new treatments or drugs will be given; instead, participants will receive the usual care from their doctors.
To join this study, women must be enrolled in the Pompe Registry and currently be pregnant, or have been pregnant in the past, with the necessary medical documentation. They need to agree to participate by signing consent forms. It's important to note that there are no exclusions based on health conditions, so any woman who meets the criteria can participate. This study is a valuable opportunity for women with Pompe disease to contribute to our understanding of how their condition interacts with pregnancy, helping improve care and outcomes for others in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- Eligible women must:
- • be enrolled in the Pompe registry (NCT00231400)
- • be pregnant, or have been pregnant with appropriate medical documentation available.
- • provide a signed informed consent and authorization form(s) to participate in the Sub-Registry prior to any Sub-Registry-related data collection being performed.
- • Note: It is recommended that pregnancy data be collected on eligible women regardless of infant enrollment. In the event of patients having multiple pregnancies, participation in this Sub-Registry is encouraged for each individual pregnancy.
- Exclusion Criteria:
- • There are no exclusion criteria for this Sub-Registry
About Genzyme, A Sanofi Company
Genzyme, a Sanofi company, is a global leader in biotechnology dedicated to developing innovative therapies for rare and complex diseases. With a strong focus on patient-centric solutions, Genzyme leverages advanced research and development capabilities to address unmet medical needs across various therapeutic areas, including neurology, oncology, and genetic disorders. Committed to scientific excellence and collaboration, Genzyme aims to improve patient outcomes through the discovery and commercialization of high-quality biopharmaceuticals, while upholding the highest standards of safety and efficacy in clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zagreb, , Croatia
Zagreb, , Croatia
Brescia, , Italy
Cagliari, , Italy
Firenze, , Italy
Genova, , Italy
Messina, , Italy
Milano, , Italy
Monza, , Italy
Padova, , Italy
Padova, , Italy
Pavia, , Italy
Roma, , Italy
Roma, , Italy
New York, New York, United States
Fairfax, Virginia, United States
Brescia, , Italy
Cagliari, , Italy
Firenze, , Italy
Genova, , Italy
Messina, , Italy
Milano, , Italy
Monza, , Italy
Padova, , Italy
Padova, , Italy
Pavia, , Italy
Roma, , Italy
Roma, , Italy
Indianapolis, Indiana, United States
New York, New York, United States
Durham, North Carolina, United States
Dublin, Ohio, United States
Grand Rapids, Michigan, United States
Fairfax, Virginia, United States
New York, New York, United States
Phoenix, Arizona, United States
Atlanta, Georgia, United States
Portland, Oregon, United States
Gent, , Belgium
Zagreb, , Croatia
Zagreb, , Croatia
Indianapolis, Indiana, United States
Grand Rapids, Michigan, United States
New York, New York, United States
New York, New York, United States
Durham, North Carolina, United States
Dublin, Ohio, United States
Fairfax, Virginia, United States
Brescia, , Italy
Cagliari, , Italy
Firenze, , Italy
Genova, , Italy
Messina, , Italy
Milano, , Italy
Monza, , Italy
Padova, , Italy
Padova, , Italy
Pavia, , Italy
Roma, , Italy
Roma, , Italy
Phoenix, Arizona, United States
Atlanta, Georgia, United States
Portland, Oregon, United States
Gent, , Belgium
Praha, , Czechia
Indianapolis, Indiana, United States
New York, New York, United States
Durham, North Carolina, United States
Dublin, Ohio, United States
Grand Rapids, Michigan, United States
Fairfax, Virginia, United States
New York, New York, United States
Portland, Oregon, United States
Milan, , Italy
Padua, , Italy
Phoenix, Arizona, United States
Atlanta, Georgia, United States
Patients applied
Trial Officials
Study Director
Study Director
Genzyme, a Sanofi Company
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials